|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1989-4-18
|
|
pubmed:abstractText |
Combination therapy with the biologically active (1-38) human parathyroid hormone peptide and calcitonin using pulsatile and sequential activation of the skeleton for 14 months in patients with low-turnover osteoporosis resulted in an increase in trabecular bone mass. These favorable responses were observed without any significant changes in cortical (forearm) bone mass content.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0171-967X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
176-80
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2493323-Administration, Intranasal,
pubmed-meshheading:2493323-Adult,
pubmed-meshheading:2493323-Aged,
pubmed-meshheading:2493323-Calcitonin,
pubmed-meshheading:2493323-Cervical Vertebrae,
pubmed-meshheading:2493323-Drug Therapy, Combination,
pubmed-meshheading:2493323-Female,
pubmed-meshheading:2493323-Humans,
pubmed-meshheading:2493323-Lumbar Vertebrae,
pubmed-meshheading:2493323-Male,
pubmed-meshheading:2493323-Middle Aged,
pubmed-meshheading:2493323-Osteoporosis,
pubmed-meshheading:2493323-Parathyroid Hormone,
pubmed-meshheading:2493323-Peptide Fragments,
pubmed-meshheading:2493323-Thoracic Vertebrae
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients.
|
|
pubmed:affiliation |
Abteilung für Klinische Endokrinologie, Medizinische Hochschule Hannover, Federal Republic of Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
